Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Cromolyn Sodium for Eosinophilic Esophagitis
NCT02371941Phase 4Completed
- Sponsor
- University of Tennessee
- Start
- Dec 2014
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sodium cromoglycate in eosinophilic esophagitis (EoE), sponsored by University of Tennessee. Started Dec 2014; status: completed.
02
Drugs
sodium cromoglycate
03
Conditions
eosinophilic esophagitis (EoE)
Beyond the preview
Go deeper on NCT02371941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02371941.